New York state is investigating six pharmaceutical companies for raising prices during the Covid-19 pandemic, in one case by more than 1,350%. The newly formed Office of Pharmacy Benefits in the state’s Department of Financial Services is conducting the investigations. The state points out that it is not yet charging that the spikes in prices…
This content is for Westfair Online members only. Please Sign in / Join to view this content. Become a member by Registering Here.
